BiosimilarsIP.com Legal provides analysis of legal decisions from federal courts and from the PTAB related to biologics and biosimilars.

  • Posted in:

    RFEM’s Biosimilars Inter Partes Review (IPR) Dashboard

    RFEM’s Biosimilars IPR Dashboard provides current information on IPR proceedings related to proposed biosimilar...

    Read more

    http://twitter.com/share?text="[TITLE]&url=[PERMALINK]

    Share, Linked In, , , Google Plus

  • Posted in:

    Litigation Spotlight: The Adello Filgrastim (Neupogen®) Litigation

    On March 8, 2018, Amgen Inc. (“Amgen”) filed suit against Adello Biologics, LLC (“Adello”) in the District of New Jersey, alleging...

    Read more

    http://twitter.com/share?text="[TITLE]&url=[PERMALINK]

    Share, Linked In, , , Google Plus

  • Posted in:

    Litigation Spotlight Update: Epogen® Litigation Status in Face of Retacrit Regulatory Approval

    As we recently covered, May 15, 2018, saw the FDA granting approval to Hospira (now a Pfizer subsidiary) for its Retacrit injection, a...

    Read more

    http://twitter.com/share?text="[TITLE]&url=[PERMALINK]

    Share, Linked In, , , Google Plus

  • Posted in:

    Immunex Loses Battle Over Institution of Follow-on IPR Petitions

    Sanofi-Aventis U.S. LLC, Genzyme Corporation, and Regeneron Pharmaceuticals, Inc. recently scored a victory in their ongoing dispute over a...

    Read more

    http://twitter.com/share?text="[TITLE]&url=[PERMALINK]

    Share, Linked In, , , Google Plus

  • Biosimilars Legal Information, Biologics Legal Information

    BiosimilarsIP.com Legal provides analysis of legal decisions from federal courts and from the PTAB related to biologics and biosimilars.

    Back to Top